Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 21286 AL 21300

Two Novel Mutations in the First Transmembrane Domain of Presenilin1 Cause Young-Onset Alzheimer's Disease

Liu CY, Ohki Y, Tomita T, Osawa S, Reed BR, Jagust W, Van Berlo V, Jin LW, Chui HC, Coppola G, Ringman JM.

J Alzheimers Dis. 2017;58(4):1035-1041. doi: 10.3233/JAD-161203.

Signs and symptoms preceding the diagnosis of Alzheimer's disease: a systematic scoping review of literature from 1937 to 2016

Bature F, Guinn BA, Pang D, Pappas Y.

BMJ Open. 2017 Aug 28;7(8):e015746. doi: 10.1136/bmjopen-2016-015746.

Clinical aspects and biomarkers of Alzheimer's disease in Down syndrome

Zis P, Strydom A.

Free Radic Biol Med. 2018 Jan;114:3-9. doi: 10.1016/j.freeradbiomed.2017.08.024. Epub 2017 Sep 1.

Glucose Transporters in Brain: In Health and in Alzheimer's Disease

Szablewski L.

J Alzheimers Dis. 2017;55(4):1307-1320. doi: 10.3233/JAD-160841.

Oxidative stress in neurodegenerative disease: causation or association?

Van Raamsdonk JM, Vega IE, Brundin P.

Oncotarget. 2017 Feb 14;8(7):10777-10778. doi: 10.18632/oncotarget.14650.

Co-occurring frontal variant Alzheimer's dementia and carrier of Huntington's disease allele with reduced penetrance

Rawtaer I, Krishnamoorthy A.

Psychogeriatrics. 2017 Nov;17(6):488-490. doi: 10.1111/psyg.12246. Epub 2017 Jan 27.

7T MRI for neurodegenerative dementias in vivo: a systematic review of the literature

McKiernan EF, O'Brien JT.

J Neurol Neurosurg Psychiatry. 2017 Jul;88(7):564-574. doi: 10.1136/jnnp-2016-315022. Epub 2017 Mar 4.

Biological Basis for Amyloidogenesis in Alzheimer's Disease

Andreeva TV, Lukiw WJ, Rogaev EI.

Biochemistry (Mosc). 2017 Feb;82(2):122-139. doi: 10.1134/S0006297917020043.

Ultra-Early Phase pathologies of Alzheimer's disease and other neurodegenerative diseases

Okazawa H.

Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(6):361-377. doi: 10.2183/pjab.93.022.

Neuroglia: Functional Paralysis and Reactivity in Alzheimer's Disease and Other Neurodegenerative Pathologies

Verkhratsky A, Zorec R, Rodriguez JJ, Parpura V.

Adv Neurobiol. 2017;15:427-449. doi: 10.1007/978-3-319-57193-5_17.

Exploring the potential of natural and synthetic neuroprotective steroids against neurodegenerative disorders: A literature review

Bansal R, Singh R.

Med Res Rev. 2018 Jul;38(4):1126-1158. doi: 10.1002/med.21458. Epub 2017 Jul 11.

Point-of-Care Devices Using Disease Biomarkers To Diagnose Neurodegenerative Disorders

Wei TY, Fu Y, Chang KH, Lin KJ, Lu YJ, Cheng CM.

Trends Biotechnol. 2018 Mar;36(3):290-303. doi: 10.1016/j.tibtech.2017.11.004. Epub 2017 Dec 11.

Neuroprotective effects of glucose-dependent insulinotropic polypeptide in Alzheimer's disease

Ji C, Xue GF, Li G, Li D, Hölscher C.

Rev Neurosci. 2016 Jan;27(1):61-70. doi: 10.1515/revneuro-2015-0021.

miRNAs as Circulating Biomarkers for Alzheimer's Disease and Parkinson's Disease

Mushtaq G, Greig NH, Anwar F, Zamzami MA, Choudhry H, Shaik MM, Tamargo IA, Kamal MA.

Med Chem. 2016;12(3):217-25. doi: 10.2174/1573406411666151030112140.

Inflammatory Process in Alzheimer's and Parkinson's Diseases: Central Role of Cytokines

Alam Q, Alam MZ, Mushtaq G, Damanhouri GA, Rasool M, Kamal MA, Haque A.

Curr Pharm Des. 2016;22(5):541-8. doi: 10.2174/1381612822666151125000300.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias